Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster StudyPRNewsWire • 12/21/21
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 VaccinePRNewsWire • 12/21/21
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAXPRNewsWire • 12/21/21
Novavax Shares Fall On Heavy Options Volume Following COVID Vaccine Approval By EUBenzinga • 12/20/21
World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 VaccinePRNewsWire • 12/20/21
European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 VaccinePRNewsWire • 12/20/21
EU regulator backs authorization for Novavax COVID-19 vaccine, sending stock up 10% premarketMarket Watch • 12/20/21
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 VaccinePRNewsWire • 12/20/21
Rosen, A Leading Law Firm, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAXNewsfile Corp • 12/18/21